InvestorsHub Logo
Followers 3
Posts 1330
Boards Moderated 0
Alias Born 09/24/2018

Re: ugly jewell post# 85164

Tuesday, 12/03/2019 3:15:19 PM

Tuesday, December 03, 2019 3:15:19 PM

Post# of 86313
The big problem with OTC tickers - and this one in particular, is that they have ZERO incentive to actually see the stock price rise. Literally, this thing could RS, take a 98% nosedive over two weeks, and NOTHING can happen to management. They don't own shares, they're not compensated if share price increases, they control the board (therego, their contracts, salary, control over expenses, etc).

I really can't imagine their position is that strong - there are clearly numerous manufacturers out there launching glasses free 3-D. If they actually controlled this market, or had their tech in every single player on the market, you would have heard about this company. Even more so, one of the big screen manufacturers would have just bought them out. Instead, they're trading on the OTC and using toxic lenders... that doesn't tie out.

Nope, still not a paid basher. Just here helping to provide clarity and understanding to complex capital structures.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.